Description

6-Cyclopropyl-3-Methylisoxazolo[5,4-B]Pyridine-4-Carboxylic Acid (Saltdata: Free) is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure, designed for the synthesis of novel active pharmaceutical ingredients (APIs). Its core value lies in enabling precise molecular construction for drug discovery and development programs targeting a range of therapeutic areas. This compound is essential for research chemists and process development scientists in the pharmaceutical, biotechnology, and fine chemical industries who require reliable, high-quality building blocks for complex organic synthesis.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel drug candidates, particularly in medicinal chemistry research.
• API Synthesis: Used as a key building block for constructing the core scaffold of potential Active Pharmaceutical Ingredients (APIs).
• Drug Discovery & Development: Facilitates structure-activity relationship (SAR) studies and the exploration of new chemical entities in preclinical research.
• Fine Chemical Manufacturing: Employed in the production of specialized, high-value chemicals for research and small-scale commercial applications.
• Contract Research & Manufacturing (CRO/CMO): A vital material for organizations providing custom synthesis and process development services.
• Academic Research: Used in university and institutional labs for methodological studies in heterocyclic and organic chemistry.

Basic Information

Product Name	6-Cyclopropyl-3-Methylisoxazolo[5,4-B]Pyridine-4-Carboxylic Acid (Saltdata: Free)
CAS No.	923258-65-5
Molecular Formula	C12H10N2O3
Molecular Weight	230.22 g/mol
Synonyms	6-Cyclopropyl-3-methylisoxazolo[5,4-b]pyridine-4-carboxylic acid; 4-Isoxazolecarboxylic acid, 6-cyclopropyl-3-methylisoxazolo[5,4-b]pyridine-; 6-Cyclopropyl-3-methyl[1,2]oxazolo[5,4-b]pyridine-4-carboxylic acid; 923258-65-5; Isoxazolopyridine-4-carboxylic acid derivative; CP-MIPCA (abbreviation); 3-Methyl-6-cyclopropylisoxazolo[5,4-b]pyridine-4-carboxylic acid
EINECS	Contact for details

Quality Control

Every batch of 6-Cyclopropyl-3-Methylisoxazolo[5,4-B]Pyridine-4-Carboxylic Acid is manufactured under strict quality management systems. Our products undergo rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency meet the exacting standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all specification results is provided with each shipment to guarantee full traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which may affect stability and handling properties. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.